Skip to content

Evaluation of Surgical Treatment of Disease involving Dental Implants

Evaluation of Surgical treatment of peri-implantitis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9d2hbm
Enrollment
Unknown
Registered
2020-04-20
Start date
2019-01-10
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peri-Implantitis

Interventions

Intervention in all groups is the surgical treatment of peri-implantitis (totaling 60 treated implants). Before surgical treatment of peri-implantitis, all patients will be submitted to non-surgical m
Procedure/surgery

Sponsors

Universidade Federal do Rio Grande do Norte
Lead Sponsor
Universidade Guarulhos
Collaborator
Universidade Paulista
Collaborator

Eligibility

Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Volunteers of both sexes; age over 18 years; toothless units, partial or total; patients with single or multiple osseointegrated implants rehabilitated with a minimum period of 12 months; patients with at least one implant with the clinical diagnosis of peri-implantitis according to the criteria of Mombelli (1999).

Exclusion criteria

Exclusion criteria: Volunteers with severe psychosomatic illnesses that prevent good oral hygiene; diagnosis of systemic conditions that make it impossible to undergo a surgical procedure; hallucinogenic or narcotic drug users; history of antibiotic and / or anti-inflammatory therapy 3 months before the initial evaluation visit; carriers of diseases that cause severe impairment of the immune system.

Design outcomes

Primary

MeasureTime frame
Main primary outcome: Decrease in the degree of peri-implant inflammation and the depth of probing, determined by probing at the beginning of the study and at the end of the study.;Expected primary outcome 2: Maintenance of bone level, determined by measuring in millimeters with a ruler on digital periapical radiography at the beginning of the study and at the end of the study.;Expected primary outcome 3: Decrease in visible biofilm, determined by the presence or absence of biofilm on the faces of teeth and prostheses at the beginning of the study and at the end of the study.

Secondary

MeasureTime frame
Expected secondary outcome 1: Maintenance of the band of keratinized mucosa, verified through the distance from the mucogingival junction to the gingival margin, measured at the midpoint of the buccal surface of teeth and implants; measured in millimeters with the aid of a millimeter probe; assessed before surgery, 6 months, 12 months and 1 year after the intervention; from the observation of the variation in the pre and post-intervention measurements.;Expected secondary outcome 2: Reduction of the oxidative stress marker malondialdehyde, verified through the reaction with thiobarbituric acid and production of a pink pigment allowing the analysis of the standard curve. The measurement will be made through a spectrophotometer, from the saliva collected on the day of the surgical procedure and 12 months after the surgery, to perform the comparison.;Expected secondary outcome 3: Reduction of the oxidative stress marker superoxide dismutase, verified by assessing its ability to inhibit the photochemical reduction of nitro-tetrazolium blue. The measurement will be made through a spectrophotometer, from the saliva collected on the day of the surgical procedure and 12 months after the surgery, to perform the comparison.;Expected secondary outcome 4: Reduction of the oxidative stress marker total antioxidant capacity, capable of measuring the antioxidant capacity of virtually all components of a biological sample. The measurement will be made through a spectrophotometer, from the saliva collected on the day of the surgical procedure and 12 months after the surgery, to perform the comparison.;Expected secondary outcome 5: Reduction of the oxidative stress marker glutathione peroxidase, verified through the consumption of Nicotinamide Adenine Dinucleotide Phosphate using the extinction length change (340 nm). The measurement will be made through a spectrophotometer, from the saliva collected on the day of the surgical procedure and 12 months after the surgery, to perform the

Countries

Brazil

Contacts

Public ContactBruno César de Gurgel

Universidade Federal do Rio Grande do Norte

bcgurgel@yahoo.com8432154100

Outcome results

None listed

Source: REBEC (via WHO ICTRP)